Browsing All Posts filed under »Considering the risks«

Is “Medication Tapering” The Best Term For Withdrawal? | Mad In America

November 9, 2012

Comments Off on Is “Medication Tapering” The Best Term For Withdrawal? | Mad In America

In the process of learning to safely reduce by tapering or choosing to do an abrupt withdrawal there is much to consider.This is vast territory with limited insight, resources or supports. YET – there is more and more information becoming available to us through those in the medical field such as Heather Ashton, who has […]

Peter Lehmann Publishing: International list of links to self-help groups and alternatives beyond psychiatry

December 18, 2011

Comments Off on Peter Lehmann Publishing: International list of links to self-help groups and alternatives beyond psychiatry

For anyone interested to read more on the issues of psychotropic drugs and safe withdrawal – this link is to the site of Peter Lehman who also presented at Alternatives in Orlando this year. His site is a wonderful resource and wanted to share so you had access to it as you create your own […]

Patients who use anti-depressants are more likely to suffer relapse, researcher finds

August 2, 2011

Comments Off on Patients who use anti-depressants are more likely to suffer relapse, researcher finds

One of the missions of this website is to provide current and relevant information about the risks of long term use of psychotropic medications. Today I wanted to share an article on recent research behind some of the questions surrounding long term use of anti-depressants and potential for relapse. I found this article via the […]

New Study: SSRI Antidepressants ‘Clinically Insignificant’ For Most People — PsyBlog

July 23, 2011

Comments Off on New Study: SSRI Antidepressants ‘Clinically Insignificant’ For Most People — PsyBlog

Things are really happening in the world of pharmaceuticals; here is a piece that came across my desk today that I thought may interest you. Note that this was published in 2008 and consider todays climate as the long term risks of using these drugs comes into the forefront.  An Excerpt from SSRI Antidepressants “Clinically […]

The New York Times’ Defense of Antidepressants | Psychology Today

July 11, 2011

Comments Off on The New York Times’ Defense of Antidepressants | Psychology Today

Very often there is nothing to be added in the way of commentary to an article. This is one of those times. Scientific Journalist, Robert Whitaker continues to question those who defend and don’t question the reality of the risks associated with the use and dependence on these drugs or the evidence that questions the […]

Psychiatric Drugs: Chemical Warfare on Humans – interview with Robert Whitaker

July 5, 2011

Comments Off on Psychiatric Drugs: Chemical Warfare on Humans – interview with Robert Whitaker

Psychiatric Drugs: Chemical Warfare on Humans – interview with Robert Whitaker. In the original workshop we took a look at some of the potential risks involved with the long term use of psychotropic drugs and the evidentiary research articulately compiled by Scientific Journalist, Robert Whitaker. Today I wanted to share an interview with Robert Whitaker […]

Medical Psychiatry Faces Its Toughest Indictment in Its 55 Years | Suite101.com

June 29, 2011

Comments Off on Medical Psychiatry Faces Its Toughest Indictment in Its 55 Years | Suite101.com

An informative article written by Advocate Ken Braiterman that points out some of the issues that Psychiatry is facing as Robert Whitakers well chronicled history of psychiatry and pharmaceuticals as the first line of defense is examined in close detail. An excerpt: Like all responsible people who challenge the value of psychiatric medication, Whitaker acknowledges […]